Sector: health
Conviction from: NASDAQ
52-week range: 90.39212.75
A biopharmaceutical company developing and commercializing therapies for rare and serious diseases, including pulmonary and inflammatory conditions.
4 tracked filer(s) hold this · 0 opened, 0 added, 3 trimmed in 30-SEP-2026
Aggregate 13FScore 62 — mean of 4 scored holder(s). Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Ancora | 42 | Holds (flat) | 200 | $22,828 | 0.0% |
| Stanley Druckenmiller / Duquesne | 91 | Trimmed -41% | 1,642,650 | $187,492 | 4.2% |
| Bridgewater | 55 | Trimmed -15% | 386,104 | $44,069,911 | 0.2% |
| Paul Tudor Jones / Tudor | 61 | Trimmed -53% | 239,100 | $27,290,874 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
6 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-09-22 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-08-22 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |